Skip to main content
OpenTrials

Clinical trial condition

Carcinoma, Non-Small-Cell Lung

Explore clinical trials studying Carcinoma, Non-Small-Cell Lung. Study availability and eligibility vary by location and protocol.

4,680 public trials 1,031 recruiting studies
Refine in advanced search Browse all conditions

Carcinoma, Non-Small-Cell Lung trial results

Recruiting

Trial of Therapeutic Cancer Vaccine OSE2101 in Patients With Non-Small Cell Lung Cancer and Secondary Resistance to Immune Checkpoint Inhibitor

NCT06472245

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • Clinical Research Advisors, LLC Beverly Hills, California, United States
  • Clinical Research Advisors - Encino Encino, California, United States
  • Clinical Research Advisors - West Hollywood Los Angeles, California, United States
  • Clinical Research Advisors - Korea Town Los Angeles, California, United States
View all 207 locations
View Trial Details
Recruiting

APG-2449 in Patients With Advanced Solid Tumors

NCT03917043

Conditions
Adenoma, Adnexal Diseases, Advanced Solid Cancer, +39 more
Locations
  • Beijing Cancer Hospital Beijing, Beijing Municipality, China
  • Fujian Medical University Union Hospital Fuzhou, Fujian, China
  • Fujian Cancer Hospital Fuzhou, Fujian, China
  • Sun-Yat Sen University Cancer Center Guangzhou, Guangdong, China
View Trial Details
Recruiting

BGB-43395 Alone or as Part of Combination Therapies in Participants With Breast Cancer and Other Advanced Solid Tumors

NCT06120283

Conditions
Advanced Breast Cancer, Advanced Solid Tumor, Breast Diseases, +20 more
Locations
  • Sarah Cannon Research Institute (Scri) At Health One Denver, Colorado, United States
  • Florida Cancer Specialists and Research Institute Lake Mary, Florida, United States
  • Karmanos Cancer Institute Detroit, Michigan, United States
  • Washington University School of Medicine St Louis, Missouri, United States
View all 63 locations
View Trial Details
Recruiting

A Study Evaluating Sotorasib Platinum Doublet Combination Versus Pembrolizumab Platinum Doublet Combination as a Front-Line Therapy in Participants With Stage IV or Advanced Stage IIIB/C Nonsquamous Non-Small Cell Lung Cancers (CodeBreaK 202)

NCT05920356

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • Sansum Clinic Santa Barbara, California, United States
  • Medical Oncology Hematology Consultants Helen F Graham Cancer Center Newark, Delaware, United States
  • University of Illinois Chicago Chicago, Illinois, United States
  • Illinois Cancer Specialists Niles, Illinois, United States
View all 403 locations
View Trial Details
Recruiting

A Study to Evaluate the Safety, Tolerability, Drug Levels, and Preliminary Efficacy of BMS-986507 Combinations in Adult Participants With Advanced Solid Tumors

NCT06618287

Conditions
Breast Cancer, Breast Diseases, Breast Neoplasms, +14 more
Locations
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • University of Miami Hospital and Clinics, Sylvester Cancer Center Miami, Florida, United States
  • Local Institution - 0065 Iowa City, Iowa, United States
  • John Theurer Cancer Center at Hackensack University Medical Center Hackensack, New Jersey, United States
View all 61 locations
View Trial Details

Related conditions